v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Total revenue $ 15,134 $ 6,909 $ 18,354 $ 11,050
Operating expenses:        
Research and development 21,127 30,414 42,447 51,045
General and administrative 8,922 6,412 17,151 12,059
Total operating expenses 30,049 36,826 59,598 63,104
Loss from operations 14,915 29,917 41,244 52,054
Interest and other income, net 81 286 133 758
Interest and other expense, net (767) (360) (1,268) (708)
Loss on extinguishment of debt 0 (1,237) 0 (1,237)
Loss before provision for income taxes 15,601 31,228 42,379 53,241
Provision for income taxes 0 0 0 5
Net loss 15,601 31,228 42,379 53,246
Net loss attributable to common shareholders $ 15,601 $ 31,228 $ 42,379 $ 53,246
Net loss per share attributable to common shareholders:        
Basic and diluted $ 0.28 $ 0.68 $ 0.78 $ 1.17
Weighted average number of shares used in net loss per share calculations:        
Basic and diluted 56,096,238 45,725,481 54,340,173 45,687,278
Research And Development Revenue | Other        
Total revenue $ 2,235 $ 2,977 $ 5,218 $ 4,444
Research And Development Revenue | Related Party        
Total revenue 12,899 3,063 13,136 3,396
Grant        
Total revenue $ 0 $ 869 $ 0 $ 3,210

Source